When Might a Patient Notice Results?
Any pain relief noticed during the trial period reflects a short-term test of stimulation, not a guaranteed long-term outcome. If permanent implantation follows, further adjustment of stimulation settings over subsequent visits is often part of optimizing results. Relief is not guaranteed and can change over time.
How Long Might the Results Last?
The duration of relief varies by patient, condition, and device type, and long-term outcomes remain an active area of research. A systematic review comparing SCS with conventional medical management found that SCS was associated with reduced pain compared with conventional management alone in the included randomized trials, though the reviewers also noted significant variability between studies due to differences in patient populations, devices, and stimulation settings. This study aimed to evaluate the efficacy and safety of spinal cord stimulation compared with conventional medical management for patients with chronic pain and found significant heterogeneity across the cohorts studied, in part because spinal cord stimulation is used for multiple chronic pain conditions. Findings from research studies describe group-level outcomes over specific follow-up periods and do not predict how long any individual patient's results will last.
How Much Does Spinal Cord Stimulation Cost?
The out-of-pocket cost of spinal cord stimulation depends on multiple factors and cannot be stated as a fixed number without insurance verification. Costs may be affected by insurance network status, deductible, copayment, coinsurance, facility fees, imaging guidance, anesthesia, and the cost of the implanted device itself.
Because SCS involves both a trial phase and, for eligible patients, a separate implant procedure, total costs can involve more than one billed encounter. Prior authorization and documentation of medical necessity are commonly required by insurers before either phase is approved.
Does Insurance Cover Spinal Cord Stimulation?
Insurance coverage for spinal cord stimulation varies by plan and typically requires documentation of medical necessity, prior conservative treatment, and a successful trial period before permanent implantation is approved. Coverage is not guaranteed simply because a provider participates with an insurer.
Many plans require evidence that other treatments, such as physical therapy, medication management, or injections, were tried first. A successful trial period, generally defined by meaningful pain reduction during the temporary test phase, is commonly a coverage requirement before permanent implantation. Even when a treatment is considered generally accepted, individual claims can still be denied based on plan-specific criteria. Patients are encouraged to review CSPM's financial policy page and verify their specific benefits before proceeding.
What Is the Success Rate of Spinal Cord Stimulation?
There is no single universal success rate for spinal cord stimulation, since outcomes are reported differently across studies and depend heavily on patient selection and diagnosis. A 2016 systematic review of randomized controlled trials evaluating SCS for chronic spinal pain assessed studies with a minimum 12-month follow-up period and graded the quality of evidence using standardized criteria. The systematic review assessed the role and effectiveness of spinal cord stimulation in chronic spinal pain by reviewing randomized controlled trials and applying Cochrane review criteria and Interventional Pain Management Techniques quality-appraisal criteria to grade the level of evidence, considering only trials with at least 12 months of follow-up. Subsequent research examining specific device systems has reported that a defined proportion of patients achieved at least a 50 percent reduction in pain intensity at one year, though such findings are specific to the device, patient population, and follow-up period studied and should not be generalized to all patients or systems. Data from one manufacturer's study supported the effectiveness of its spinal cord stimulation system in treating people with chronic, difficult-to-manage low back and leg pain without prior back surgery, reporting that a subset of patients receiving the therapy experienced a 50 percent or greater reduction in average pain intensity sustained over one year. Because study designs, patient populations, and definitions of success differ, no single statistic can predict an individual patient's outcome.
What Are the Risks and Side Effects?
As with any implanted device procedure, spinal cord stimulation carries risks in addition to possible benefit, and these risks should be weighed individually with a physician. Common temporary effects can include soreness at the lead or device site and temporary changes in sensation. Less common risks can include lead migration (movement of the lead from its original position), infection, or device-related discomfort. Rare but serious complications can include spinal fluid leak, bleeding, or nerve injury. Patients should promptly report fever, worsening pain, new weakness or numbness, or signs of infection at the incision site to their physician.
What Are the Alternatives to Spinal Cord Stimulation?
Alternatives that may be considered instead of, or before, spinal cord stimulation include physical therapy, activity modification, medication management, epidural steroid injection or facet injections, radiofrequency ablation, other forms of neuromodulation such as DRG stimulation, and, in some cases, surgical consultation. The appropriateness of any alternative depends on the specific diagnosis and prior treatment history, and no single option is right for every patient.